Table 2. Adjusted Hazard ratio of developing dementia when taking a PPI compared to a control population using a retrospective cohort.
Hazard ratio | 95% CI | |
---|---|---|
PPI | 0.67 | 0.65 to 0.69* |
Adjusted for: | ||
Age | 1.06 | 1.05 to 1.06* |
Smoker | 0.89 | 0.85 to 0.92* |
BMI | 0.95 | 0.95 to 0.95* |
Diabetes | 1.18 | 1.14 to 1.22* |
Cardiovascular disease | 0.93 | 0.90 to 0.97* |
Depression | 1.19 | 1.16 to 1.23* |
Head injury | 1.50 | 1.43 to 1.56* |
Vitamin-B12 Deficiency | 1.37 | 1.21 to 1.56* |
Anxiolytics | 1.62 | 1.57 to 1.67* |
Antidepressants | 1.66 | 1.61 to 1.72* |
Anticoagulants | 0.87 | 0.84 to 0.89* |
Antiplatelets | 1.72 | 1.66 to 1.79* |
Statins | 0.86 | 0.85 to 0.94* |
Hormone replacement therapy | 0.89 | 0.85 to 0.94* |
Vitamin-B12 Medication | 1.41 | 1.34 to 1.48* |
Anaemia Medication | 1.10 | 1.06 to 1.13* |
Antihypertensives | 0.71 | 0.69 to 0.74* |
Histamine Receptor-2 Medication | 0.89 | 0.85 to 0.94* |
*P < 0.05.
Gender, Anaemia and alcohol use were included in the model, but removed as did not reach statistical significance.